While AAVs are generally considered safe, there are some risks associated with their use in gene therapy. These include potential immune responses to the viral vector, insertional mutagenesis (where the inserted gene disrupts other important genes), and the possibility of off-target effects. Ongoing research is focused on minimizing these risks to ensure the safety and efficacy of AAV-based therapies.
